Nis Register Study Comparing Seroquel and Seroquel Prolong

Official Title: “A Local Non Interventional Retrospective Register Study of the Current Clinical Treatment Practices and the Number of Hospitalization Days With Seroquel or Seroquel Prolong.”

The general aim of this non interventional study is to clarify what are the current clinical treatment practices of Quetiapine Immediate Release and Quetiapine Extended Release. The primary objectives of the study are:1.To collect information on the used Quetiapine Immediate Release or Quetiapine Extended Release medication 2.To collect information on duration and number of hospitalisation days 3.Change of GAF points

Arms, Groups and Cohorts in this Clinical Trial

• : 1
  • Seroquel
• : 2
  • Seroquel Prolong

Primary Measures

• Hospitalisation time
  • Time Frame: 2008-2010
    Safety Issue?: No
• Treatment practice
  • Time Frame: 2008-2010
    Safety Issue?: No

Secondary Measures

• Primary diagnosis
  • Time Frame: 2008-2010
    Safety Issue?: No
• Medication at the end of hospitalisation
  • Time Frame: 2008-2010
    Safety Issue?: No
• GAF rating points
  • Time Frame: 2008-2010
    Safety Issue?: No

Inclusion Criteria:

• Medication: Seroquel or Seroquel Prolong
• Diagnosis: F20-F29 or F30-F31 (ICD-10)
• In-patient

Exclusion Criteria:

• None

Gender Eligibility for this Clinical Trial: Both

Minimum Age for this Clinical Trial: N/A

Maximum Age for this Clinical Trial: N/A

Are Healthy Volunteers Accepted for this Clinical Trial?: No

Lead Investigator: AstraZeneca Industry

Overall Clinical Trial Officials and Contacts

Yrjö Ovaskainen Study Director Medical Affairs Manager, MD, psychiatrist  

Information obtained from ClinicalTrials.gov on February 12, 2012

Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00965536

Study ID Number: NIS-NFI-SER-2009/1

ClinicalTrials.gov Identifier: NCT00965536

Health Authority: Finland: Finnish Medicines Agency